Related Experiment Video
Updated: Aug 11, 2026

Visualizing Lymph Node Structure and Cellular Localization using Ex-Vivo Confocal Microscopy
Published on: August 9, 2019
[Morphometric study of lymphoid cells from non-Hodgkin lymphoma and reactive lymphadenitis]
Insights
Morphometric analysis of lymphoid cells shows malignant cells in non-Hodgkin lymphoma have larger area, perimeter, and nucleus diameter than benign cells. These distinct features aid in accurately identifying lymphoproliferative lesions.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Context:
- Distinguishing between malignant and benign lymphoproliferative processes is crucial for effective patient management.
- Non-Hodgkin lymphoma (NHL) diagnosis can be challenging, necessitating objective diagnostic markers.
Purpose:
- To investigate and compare morphometric parameters of lymphoid cells in non-Hodgkin lymphoma (NHL) and benign lymphoproliferative conditions.
- To identify objective cellular features that can differentiate between malignant and benign lymphoid lesions.
Summary:
- Malignant lymphoid cells in non-Hodgkin lymphoma exhibit significantly higher values for area, perimeter, and nucleus diameter compared to benign lymphoproliferative cells.
- Shape coefficients also differ between malignant and benign lymphoid cells, providing additional discriminatory information.
- These morphometric differences serve as objective criteria for the differential diagnosis of lymphoproliferative disorders.
Impact:
- Provides objective, quantitative data to improve the accuracy of diagnosing non-Hodgkin lymphoma.
- Enhances the differential diagnosis of lymphoproliferative lesions, potentially reducing misdiagnosis rates.
- Supports the integration of morphometric analysis into routine diagnostic workflows for hematologic malignancies.
Abstract:
A study of morphometric parameters of lymphoid cells reveals reliably higher parameters of area, perimeter as well as coefficients of shape and nucleus diameter of malignant cells in non-Hodgkin lymphoma versus the analogical indices observed in benign lymphoproliferative processes, which is an objective differential-diagnostic feature contributing to an accurate identification of lymphoproliferative lesions.

